Huo L - Search Results

1

Which threshold for ER positivity? a retrospective study based on 9639 patients.

Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Buzdar AU, Symmans WF, Crow JR, Bender M, Shah RR, Hortobagyi GN, Hunt KK. Yi M, et al. Among authors: huo l. Ann Oncol. 2014 May;25(5):1004-11. doi: 10.1093/annonc/mdu053. Epub 2014 Feb 20. Ann Oncol. 2014. PMID: 24562447 Free PMC article.

2

Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.

Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E. Huo L, et al. Cancer. 2006 Oct 15;107(8):1760-8. doi: 10.1002/cncr.22216. Cancer. 2006. PMID: 16977650 Free article.

3

Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment.

Brown AS, Hunt KK, Shen J, Huo L, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Boughey JC, Ching CD, Gilcrease MZ. Brown AS, et al. Among authors: huo l. Cancer. 2010 Jun 15;116(12):2878-83. doi: 10.1002/cncr.25066. Cancer. 2010. PMID: 20564394 Free PMC article.

4

Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers.

Lester TR, Hunt KK, Nayeemuddin KM, Bassett RL Jr, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis WG, Valero V, Gilcrease MZ. Lester TR, et al. Among authors: huo l. Breast Cancer Res Treat. 2012 Jan;131(1):41-8. doi: 10.1007/s10549-011-1393-6. Epub 2011 Feb 18. Breast Cancer Res Treat. 2012. PMID: 21331622 Free PMC article.

5

Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation.

Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton L, Sahin A, Xing Y, Hunt KK, Chen J, Bu H, Rashid A, Abraham SC, Wu Y. Tian Z, et al. Among authors: huo l. Hum Pathol. 2011 Aug;42(8):1169-77. doi: 10.1016/j.humpath.2010.11.014. Epub 2011 Feb 21. Hum Pathol. 2011. PMID: 21334720

6

Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer.

Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT. Huo L, et al. Histopathology. 2013 Jan;62(2):267-74. doi: 10.1111/j.1365-2559.2012.04344.x. Epub 2012 Sep 11. Histopathology. 2013. PMID: 22963676 Free PMC article.

7

Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.

Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt KK, Huo L, Babiera GV. Akay CL, et al. Among authors: huo l. Cancer. 2014 May 1;120(9):1319-28. doi: 10.1002/cncr.28550. Epub 2014 Feb 7. Cancer. 2014. PMID: 24510381 Free PMC article.

8

Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.

Rueth NM, Black DM, Limmer AR, Gabriel E, Huo L, Fornage BD, Dogan BE, Chavez-MacGregor M, Yi M, Hunt KK, Strom EA. Rueth NM, et al. Among authors: huo l. Ann Surg Oncol. 2015 Jan;22(1):90-5. doi: 10.1245/s10434-014-3991-0. Epub 2014 Sep 24. Ann Surg Oncol. 2015. PMID: 25249256 Clinical Trial.

9

GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry.

Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. Huo L, et al. Histopathology. 2015 Aug;67(2):245-54. doi: 10.1111/his.12645. Epub 2015 Feb 23. Histopathology. 2015. PMID: 25564996

10

MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.

Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, Liu CG, Liu X, Lin F, Symmans WF, Wei W, Zhang X, Sun L, Alvarez RH, Ueno NT, Fouad TM, Harano K, Debeb BG, Wu Y, Reuben J, Cristofanilli M, Zuo Z. Huo L, et al. Mod Pathol. 2016 Apr;29(4):330-46. doi: 10.1038/modpathol.2016.38. Epub 2016 Feb 26. Mod Pathol. 2016. PMID: 26916073 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,424 results

Search Page